Allison L. Zulli

发表

The synthesis and SAR of new 4-(N-alkyl-N-phenyl)amino-6,7-dimethoxyquinazolines and 4-(N-alkyl-N-phenyl)aminopyrazolo[3,4-d]pyrimidines, inhibitors of CSF-1R tyrosine kinase activity

D. Cheney, A. Zilberstein, M. Myers, 1997 .

The preparation and sar of 4-(anilino), 4-(phenoxy), and 4-(thiophenoxy)-quinazolines: Inhibitors of p56lck and EGF-R tyrosine kinase activity

A. Zilberstein, M. Myers, N. Setzer, 1997 .

A selective, orally bioavailable 1,2,4-triazolo[1,5-a]pyridine-based inhibitor of Janus kinase 2 for use in anticancer therapy: discovery of CEP-33779.

Jennifer L. Mason, Pawel Dobrzanski, Bruce D. Dorsey, 2012, Journal of medicinal chemistry.

Substituted phenoxypropyl-(R)-2-methylpyrrolidine aminomethyl ketones as histamine-3 receptor inverse agonists.

Allison L. Zulli, E. Bacon, R. Raddatz, 2012, Bioorganic & medicinal chemistry letters.

Dispersion of titanium dioxide pigments by alkyl polyglycoside surfactants in aqueous solution

Allison L. Zulli, M. D. Grieser, George A. Smith, 1994 .

Optimization of the beta-aminoester class of factor Xa inhibitors. Part 1: P(4) and side-chain modifications for improved in vitro potency.

C. Dunwiddie, D. Cheney, A. Spada, 2002, Bioorganic & medicinal chemistry letters.

TIE-2/VEGF-R2 SAR and in vitro activity of C3-acyl dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole analogs.

Allison L. Zulli, B. Ruggeri, T. Underiner, 2008, Bioorganic & medicinal chemistry letters.

Novel C-3 N-urea, amide, and carbamate dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole analogs as potent TIE-2 and VEGF-R2 dual inhibitors.

Allison L. Zulli, Hong Chang, C. Robinson, 2006, Bioorganic & medicinal chemistry letters.

The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity

Allison L. Zulli, R. Parchment, B. Ruggeri, 2007, Molecular Cancer Therapeutics.

Potent quinoxaline-based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR exploration and effective bioisosteric replacement of a phenyl substituent.

M. Myers, Wei He, N. Setzer, 2003, Bioorganic & medicinal chemistry letters.

4,5-dihydropyridazin-3-one derivatives as histamine H₃ receptor inverse agonists.

Allison L. Zulli, D. Dunn, R. Raddatz, 2012, Bioorganic & medicinal chemistry letters.

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes

D. Daigle, Allison L. Zulli, Bin Liu, 2021, Journal of medicinal chemistry.

4-phenoxypiperidine pyridazin-3-one histamine H(3) receptor inverse agonists demonstrating potent and robust wake promoting activity.

Allison L. Zulli, R. Haltiwanger, R. Raddatz, 2012, Bioorganic & medicinal chemistry letters.

Identification of pyridazin-3-one derivatives as potent, selective histamine H₃ receptor inverse agonists with robust wake activity.

Allison L. Zulli, E. Bacon, V. R. Marcy, 2011, Bioorganic & medicinal chemistry letters.

Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]

Allison L. Zulli, E. Bacon, B. Ruggeri, 2012, Journal of medicinal chemistry.

8-THP-DHI analogs as potent Type I dual TIE-2/VEGF-R2 receptor tyrosine kinase inhibitors.

A. Fedorov, E. Fedorov, S. Almo, 2010, Bioorganic & medicinal chemistry letters.

Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases.

Allison L. Zulli, E. Bacon, B. Ruggeri, 2008, Bioorganic & medicinal chemistry letters.

Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity.

Daniel L Cheney, C. Dunwiddie, D. Cheney, 2002, Bioorganic & medicinal chemistry letters.